Wilmington Savings Fund Society FSB Grows Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Wilmington Savings Fund Society FSB raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 209.9% during the third quarter, according to its most recent filing with the SEC. The firm owned 28,886 shares of the healthcare conglomerate's stock after purchasing an additional 19,566 shares during the period. Wilmington Savings Fund Society FSB's holdings in UnitedHealth Group were worth $16,889,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the business. Delta Financial Group Inc. lifted its holdings in shares of UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate's stock worth $965,000 after purchasing an additional 17 shares during the period. Signature Resources Capital Management LLC raised its holdings in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 18 shares in the last quarter. Saxony Capital Management LLC increased its position in UnitedHealth Group by 3.5% during the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate's stock worth $270,000 after purchasing an additional 18 shares during the period. GoalVest Advisory LLC lifted its holdings in shares of UnitedHealth Group by 0.6% in the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate's stock valued at $1,591,000 after buying an additional 18 shares during the period. Finally, Fiduciary Group LLC grew its holdings in UnitedHealth Group by 0.5% during the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate's stock worth $1,882,000 after acquiring an additional 18 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

Several brokerages have commented on UNH. Truist Financial restated a "buy" rating and set a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Hsbc Global Res cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Thursday, October 17th. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Monday. Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating on the stock in a report on Wednesday, October 16th. Finally, UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. Three investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $626.84.

UnitedHealth Group Trading Down 3.3 %

Shares of NYSE:UNH traded down $17.80 during midday trading on Thursday, reaching $515.73. The company's stock had a trading volume of 9,397,713 shares, compared to its average volume of 3,967,591. The business has a 50 day moving average price of $584.83 and a 200 day moving average price of $559.60. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a market cap of $474.62 billion, a price-to-earnings ratio of 34.45, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same period in the prior year, the firm posted $6.56 EPS. The company's revenue was up 9.2% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.